DG
26
-2
REGN
71
6
NRG
80
3
D
46
11
KEY
53
2
SYK
42
-13
GD
66
2
NWS
79
15
NUE
44
5
HON
58
4
HCA
50
2
HPE
17
5
BWA
64
3
NDAQ
49
7
TROW
58
2
WM
70
2
NVDA
63
4
AVGO
42
2
INTU
69
4
GPC
56
2
DG
26
-2
REGN
71
6
NRG
80
3
D
46
11
KEY
53
2
SYK
42
-13
GD
66
2
NWS
79
15
NUE
44
5
HON
58
4
HCA
50
2
HPE
17
5
BWA
64
3
NDAQ
49
7
TROW
58
2
WM
70
2
NVDA
63
4
AVGO
42
2
INTU
69
4
GPC
56
2
Financhill
Back

Mithra Pharmaceuticals SA 10K Form

Sell
45

MITPF
Mithra Pharmaceuticals SA

Last Price:
6.75
Seasonality Move:
0%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MITPF News And Ratings

See the #1 stock for the next 7 days that we like better than MITPF

MITPF Financial Statistics

Sales & Book Value

Annual Sales: $70.65M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $-0.16
Price / Book: 0

Profitability

EPS (TTM): -1.50150
Net Income (TTM): $-84.05M
Gross Margin: $49.96M
Return on Equity: -391.67%
Return on Assets: -18.91%

Mithra Pharmaceuticals SA Earnings Forecast

Key Mithra Pharmaceuticals SA Financial Ratios

  • The Gross Profit Margin over the past 11 years for MITPF is 70.71%.
  • The Selling, General & Administrative Expenses for MITPF have been equal to 25.04% of Gross Profit Margin.
  • The Research & Development expenses have been 95.59% of Revenue.
  • The Interest Expense is -28.52% of Operating Income.
  • The Net Earning history of MITPF is -88.99% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 3 years.

Mithra Pharmaceuticals SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: MITPF
Website: mithra.com

Debt

Debt-to-Equity Ratio: -19.15
Current Ratio: 1.04
Quick Ratio: 0.49

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MITPF Technical Analysis vs Fundamental Analysis

Sell
45
Mithra Pharmaceuticals SA (MITPF) is a Sell

Is Mithra Pharmaceuticals SA a Buy or a Sell?